Davidson Kempner Amends Angel Oak Mortgage REIT Filing
Ticker: AOMN · Form: SC 13D/A · Filed: Jul 22, 2024 · CIK: 1766478
| Field | Detail |
|---|---|
| Company | Angel Oak Mortgage Reit, Inc. (AOMN) |
| Form Type | SC 13D/A |
| Filed Date | Jul 22, 2024 |
| Risk Level | medium |
| Pages | 6 |
| Reading Time | 7 min |
| Key Dollar Amounts | $0.01, $5.0 million, $20.0 million, $25.0 million, $50.0 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: 13d-amendment, stakeholder-update, real-estate-reit
Related Tickers: AOMR
TL;DR
Davidson Kempner Capital Management LP updated its Angel Oak Mortgage REIT stake filing on 7/22/24.
AI Summary
Davidson Kempner Capital Management LP has amended its Schedule 13D filing regarding Angel Oak Mortgage REIT, Inc. as of July 22, 2024. The filing indicates a change in beneficial ownership, though specific new holdings or percentage changes are not detailed in this excerpt. Davidson Kempner Capital Management LP is a significant investment management firm.
Why It Matters
This amendment signals potential shifts in significant stakeholder positions within Angel Oak Mortgage REIT, Inc., which could influence the company's strategic direction or stock performance.
Risk Assessment
Risk Level: medium — Amendments to Schedule 13D filings by large investment firms can indicate strategic moves or changes in investment thesis, potentially impacting stock price.
Key Players & Entities
- Angel Oak Mortgage REIT, Inc. (company) — Subject Company
- Davidson Kempner Capital Management LP (company) — Filing Party
FAQ
What is the primary purpose of this SC 13D/A filing?
This filing is an amendment (Amendment No. 2) to a Schedule 13D, indicating a change in beneficial ownership of Angel Oak Mortgage REIT, Inc. by Davidson Kempner Capital Management LP.
Who is the subject company of this filing?
The subject company is Angel Oak Mortgage REIT, Inc.
Who is the entity filing the amendment?
The entity filing the amendment is Davidson Kempner Capital Management LP.
What is the date of this filing?
The filing was made on July 22, 2024.
What type of securities are being reported on?
The filing pertains to the Common Stock of Angel Oak Mortgage REIT, Inc., with a par value of $0.01.
Filing Stats: 1,737 words · 7 min read · ~6 pages · Grade level 12.1 · Accepted 2024-07-22 16:15:10
Key Financial Figures
- $0.01 — me of Issuer) Common Stock, par value $0.01 par value per share (Title of Class of
- $5.0 million — with the Issuer, to repurchase between $5.0 million and $20.0 million of shares of Common S
- $20.0 million — to repurchase between $5.0 million and $20.0 million of shares of Common Stock owned by Xyle
- $25.0 million — ate repurchase price of $5.0 million if $25.0 million in aggregate principal amount of notes
- $50.0 million — te repurchase price of $20.0 million if $50.0 million in aggregate principal amount of notes
- $50.0 thousand — in such ranges, less an amount equal to $50.0 thousand. If more than $50.0 million in aggregat
- $20.0 m — having an aggregate repurchase price of $20.0 million, less an amount equal to $50.0 th
Filing Documents
- p24-2377sc13da.htm (SC 13D/A) — 61KB
- 0000902664-24-004809.txt ( ) — 63KB
of the Schedule
Item 1 of the Schedule 13D is hereby amended and restated as follows: This statement on Schedule 13D (the “ Schedule 13D ”) relates to the Common Stock, par value $0.01 per share (the “ Common Stock ”) of Angel Oak Mortgage REIT, Inc., a Maryland corporation (the “ Issuer ”). The Issuer’s principal executive offices are located at 3344 Peachtree Road NE, Suite 1725, Atlanta, Georgia 30326. Item 4. PURPOSE OF TRANSACTION
of the Schedule 13D is hereby supplemented by the addition of the following
Item 4 of the Schedule 13D is hereby supplemented by the addition of the following: On July 18, 2024, Xylem entered into a stock repurchase agreement (the " Stock Repurchase Agreement ") with the Issuer, to repurchase between $5.0 million and $20.0 million of shares of Common Stock owned by Xylem (the " Share Repurchase "). Specifically, pursuant to the Stock Repurchase Agreement, the Issuer has agreed to repurchase from Xylem, as soon as practicable following the initial closing of the Issuer's underwritten public offering of senior notes due 2029 (the " Notes Offering "), shares of Common Stock at a purchase price per share based on (1) the volume-weighted average price of shares of the Common Stock for the five trading days up to and including the trading day immediately preceding the launch of the Notes Offering less (2) a discount of 3.15% of the share price determined pursuant to clause (1) above. The Stock Repurchase Agreement provides that the aggregate repurchase price to be paid to Xylem in the Share Repurchase is dependent on the aggregate principal amount of the notes sold in the Notes Offering and ranges from (1) an aggregate repurchase price of $5.0 million if $25.0 million in aggregate principal amount of notes are sold in the Notes Offering (excluding any amounts sold pursuant to the underwriters exercise of any over-allotment option) to (2) an aggregate repurchase price of $20.0 million if $50.0 million in aggregate principal amount of notes are sold in the Notes Offering (excluding any amounts sold pursuant to the underwriters exercise of any over-allotment option) with the aggregate repurchase price being determined based on linear interpolation within such ranges, less an amount equal to $50.0 thousand. If more than $50.0 million in aggregate principal amount of notes are sold in the Notes Offering (excluding any amounts sold pursuant to the underwriters exercise of any over-allotment option), the Issuer will repurchase shares of Common Sto
of the Schedule 13D is hereby supplemented by the addition of the following
Item 7 of the Schedule 13D is hereby supplemented by the addition of the following: Exhibit 99.4: Stock Repurchase Agreement, dated July 18, 2024, between the Issuer and Xylem (incorporated by reference to Exhibit 10.1 to the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on July 18, 2024). CUSIP No. 03464Y108 SCHEDULE 13D/A Page 7 of 7 Pages
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. DATE: July 22, 2024 /s/ Anthony A. Yoseloff ANTHONY A. YOSELOFF, ( i) individually, (ii) as Executive Managing Member of: (a) Davidson Kempner Capital Management LP, (x) for itself and (y) as Investment Manager of Xylem Finance LLC.